Effects of extracorporeal shock wave lithotripsy on cardiac pacemakers and its safety in patients with implanted cardiac pacemakers.
Pacing and clinical electrophysiology : PACE · 1988 · Vol. 11 · Issue 11 Pt 1 · 1607-16
Academy Summary
Cooper and colleagues investigated the interaction between extracorporeal shock wave lithotripsy (SWL) and implanted cardiac pacemakers using both laboratory testing and a small clinical patient series.
The study evaluated 15 pacemakers in vitro:
- 5 standard single-chamber pacemakers
- 6 dual-chamber pacemakers
- 4 rate-responsive single-chamber pacemakers
The devices were exposed to an average of approximately 1,300 shock waves from a Dornier HM3 lithotripter while positioned at the second focal point, F2, representing the location of maximum shock-wave pressure. (pubmed.ncbi.nlm.nih.gov)
The investigators deliberately programmed the pacemakers to sensitive settings to evaluate potential interference under demanding experimental conditions.
Important device-specific effects were observed.
With dual-chamber pacemakers, an atrial paced event could trigger lithotripter discharge and lead to temporary inhibition of ventricular pacing output in two devices. This problem disappeared when pacemaker sensitivity was reduced.
Despite direct exposure to shock waves, the:
- Pacemaker casing
- Hermetic seal
- Internal circuitry
remained physically intact in all tested devices.
However, rate-responsive pacemakers using piezoelectric activity sensors behaved differently.
Two such devices positioned directly at F2 sustained physical damage to their activity-sensing piezoelectric components.
Two additional rate-responsive devices positioned approximately 5 cm away from F2 were driven to their maximum programmed pacing rate during SWL, although they otherwise remained functional. (pubmed.ncbi.nlm.nih.gov)
Following the laboratory investigation, six patients with thoracic pacemakers underwent clinical SWL.
Five patients had pacemakers programmed in VVI mode and one in DDD mode.
All six underwent SWL successfully without:
- Pacemaker malfunction
- Significant pacing disturbance
- Clinically important arrhythmia
The study therefore provided early experimental and clinical evidence that a cardiac pacemaker was not necessarily an absolute contraindication to SWL, but that device type, sensing technology, programming and position relative to the shock-wave focus were important safety considerations. (pubmed.ncbi.nlm.nih.gov)
Comments & Discussion0 comments
Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.
No comments yet. Start the discussion.
Please log in to join the discussion.
